Stefan N Symeonides (Stefan Symeonides)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Dna Damage Response

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Life science alliance

British journal of cancer

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno, Loredana Siani, Rosa Vitale, Valentino Ruzza, Irene Garzia, Laura Antonucci, Elisa Micarelli, Veronica Venafra, Sven Gogov, Alessia Capone, Sarah Runswick, Juan Martín-Liberal, Emiliano Calvo, Victor Moreno, Stefan N Symeonides, Elisa Scarselli, Oliver Bechter
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno, Loredana Siani, Rosa Vitale, Valentino Ruzza, Irene Garzia, Laura Antonucci, Elisa Micarelli, Veronica Venafra, Sven Gogov, Alessia Capone, Sarah Runswick, Juan Martín-Liberal, Emiliano Calvo, Victor Moreno, Stefan N Symeonides, Elisa Scarselli, Oliver Bechter
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno, Loredana Siani, Rosa Vitale, Valentino Ruzza, Irene Garzia, Laura Antonucci, Elisa Micarelli, Veronica Venafra, Sven Gogov, Alessia Capone, Sarah Runswick, Juan Martín-Liberal, Emiliano Calvo, Victor Moreno, Stefan N Symeonides, Elisa Scarselli, Oliver Bechter
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno, Loredana Siani, Rosa Vitale, Valentino Ruzza, Irene Garzia, Laura Antonucci, Elisa Micarelli, Veronica Venafra, Sven Gogov, Alessia Capone, Sarah Runswick, Juan Martín-Liberal, Emiliano Calvo, Victor Moreno, Stefan N Symeonides, Elisa Scarselli, Oliver Bechter
Phase I trial of viral vector based personalized vaccination elicits robust neoantigen specific antitumor T cell responses. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno, Loredana Siani, Rosa Vitale, Valentino Ruzza, Irene Garzia, Laura Antonucci, Elisa Micarelli, Veronica Venafra, Sven Gogov, Alessia Capone, Sarah Runswick, Juan Martín-Liberal, Emiliano Calvo, Victor Moreno, Stefan N Symeonides, Elisa Scarselli, Oliver Bechter
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Georges Bedran, Hans-Christof Gasser, Kenneth Weke, Tongjie Wang, Dominika Bedran, Alexander Laird, Christophe Battail, Fabio Massimo Zanzotto, Catia Pesquita, Håkan Axelson, Ajitha Rajan, David J Harrison, Aleksander Palkowski, Maciej Pawlik, Maciej Parys, J Robert O'Neill, Paul M Brennan, Stefan N Symeonides, David R Goodlett, Kevin Litchfield, Robin Fahraeus, Theodore Hupp, Sachin Kote, Javier Antonio Alfaro
The immunopeptidome from a genomic perspective: Establishing the non-canonical landscape of MHC class I-associated peptides. Cancer immunology research (2023)
Rebecca S Kristeleit, Ruth Plummer, Robert Jones, Louise Carter, Sarah P Blagden, Debashis Sarker, Tobias Arkenau, Thomas R Jeffry Evans, Sarah Danson, Stefan N Symeonides, Gareth J Veal, Barbara J Klencke, Mark M Kowalski, Udai Banerji
A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer. British journal of cancer (2023)
Katerina Boufea, Victor Gonzalez-Huici, Marcus Lindberg, Nelly N Olova, Stefan N Symeonides, Olga Oikonomidou, Nizar N Batada
Correction: Single-cell RNA sequencing of human breast tumour-infiltrating immune cells reveals a γδ T-cell subtype associated with good clinical outcome. Life science alliance 6 (2) (2022)
Katerina Boufea, Victor Gonzalez-Huici, Marcus Lindberg, Nelly N Olova, Stefan N Symeonides, Olga Oikonomidou, Nizar N Batada
Correction: Single-cell RNA sequencing of human breast tumour-infiltrating immune cells reveals a γδ T-cell subtype associated with good clinical outcome. Life science alliance 6 (2) (2022)
Katerina Boufea, Victor Gonzalez-Huici, Marcus Lindberg, Nelly N Olova, Stefan N Symeonides, Olga Oikonomidou, Nizar N Batada
Correction: Single-cell RNA sequencing of human breast tumour-infiltrating immune cells reveals a γδ T-cell subtype associated with good clinical outcome. Life science alliance 6 (2) (2022)
Hagen Schwenzer, Erica De Zan, Mustafa Elshani, Ruud van Stiphout, Mary Kudsy, Josephine Morris, Valentina Ferrari, In Hwa Um, James Chettle, Farasat Kazmi, Leticia Campo, Alistair Easton, Sebastian Nijman, Michaela Serpi, Stefan N Symeonides, Ruth Plummer, David J Harrison, Gareth Bond, Sarah P Blagden
The Novel Nucleoside Analogue ProTide NUC-7738 Overcomes Cancer Resistance Mechanisms In Vitro and in a First-In-Human Phase I Clinical Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (23) (2021)